Success Metrics

Clinical Success Rate
98.4%

Based on 60 completed trials

Completion Rate
98%(60/61)
Active Trials
44(25%)
Results Posted
3%(2 trials)
Terminated
1(1%)

Phase Distribution

Ph not_applicable
15
9%
Ph phase_2
1
1%
Ph early_phase_1
1
1%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution17 total trials
Early Phase 1First-in-human
1(5.9%)
Phase 2Efficacy & side effects
1(5.9%)
N/ANon-phased studies
15(88.2%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

96.8%

60 of 62 finished

Non-Completion Rate

3.2%

2 ended early

Currently Active

44

trials recruiting

Total Trials

176

all time

Status Distribution
Active(84)
Completed(60)
Terminated(2)
Other(30)

Detailed Status

Completed60
Recruiting37
Not yet recruiting33
unknown30
Enrolling by invitation7
Active, not recruiting7

Development Timeline

Analytics

Development Status

Total Trials
176
Active
44
Success Rate
98.4%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (5.9%)
Phase 21 (5.9%)
N/A15 (88.2%)

Trials by Status

enrolling_by_invitation74%
not_yet_recruiting3319%
terminated11%
recruiting3721%
unknown3017%
completed6034%
active_not_recruiting74%
withdrawn11%

Recent Activity

Clinical Trials (176)

Showing 20 of 176 trialsScroll for more
NCT07856563

Vaccine Knowledge, Attitudes and Practices Among Men Who Have Sex With Men: a Global Cross-sectional Study

Not Yet Recruiting
NCT07842185Phase 2

A Multicenter, Three-Arm, Open-Label, Endpoint-Blinded Randomized Controlled Trial to Evaluate the Optimal Duration of Early Tirofiban After Intravenous Thrombolysis in Acute Ischemic Stroke

Not Yet Recruiting
NCT07788313

Mechanical Power-Integrated Oxygenation Indices for Predicting Postoperative Pulmonary Complications After Major Abdominal Surgery

Completed
NCT07785804Not Applicable

Effectiveness of the SelfBack-App in Preventing and Treating Low Back Pain Versus no Intervention: a Non-randomized Clinical Trial

Enrolling By Invitation
NCT05750498

A-LiNK: Improving Outcomes in Autoimmune Liver Disease

Recruiting
NCT07770334

Procalcitonin as a Prognostic Predictor in Patients With Acute Infectious Disease Hospitalized in the Internal Medicine Department.

Not Yet Recruiting
NCT06824493

Orthodontic Treatment on Oral Microbiota and Salivary Proteins

Recruiting
NCT07761208

Turkish Version of the Pictorial Pain Interference Questionnaire

Not Yet Recruiting
NCT05645835Not Applicable

Dynamic Neural Systems Underlying Social-emotional Functions in Older Adults

Active Not Recruiting
NCT07739784

This Study Examines Whether Personality Traits Influence the Frequency or Severity of Ocular Adverse Effects Reported by Patients Using Glaucoma Medications. The Findings May Identify Patients at Greater Risk of Intolerance and Support More Personalized Treatment and Counselling.

Recruiting
NCT07734428

Inflammation and Diabetes: Evaluating Antioxidant Levels

Not Yet Recruiting
NCT07720830

Identification of Genetic Variants Associated With Lichen Sclerosus

Recruiting
NCT07715981Not Applicable

Easy-to-use, Live, Interactive Support Avatar

Not Yet Recruiting
NCT07299981

Quantitative Net Water Uptake as a Predictor of Functional Outcomes After Intravenous Thrombolysis in Acute Ischemic Stroke International Multicenter Observational Retrospective Study

Recruiting
NCT07699081

Factors Affecting Physical Activity Levels and Preferences

Completed
NCT07693647

Evaluation of Pelvic Floor Function and Psychosocial Sequelae Following Radical Prostatectomy for Prostate Cancer

Enrolling By Invitation
NCT07656324

Epidemiology and Prognostic Analysis of Chinese Cancer Patients With Cancer-related Fatigue

Recruiting
NCT07653893

A Phase II Observational Clinical Study on the Relationship Between Cerebrospinal Fluid Drug Concentration and Efficacy of Trastuzumab Deruxtecan in Central Nervous System Metastatic Breast Cancer

Recruiting
NCT07624630

Walking and Thinking - Brain Activity During Complex Walking in Stroke

Recruiting
NCT03403257

Brain Attack Surveillance in Corpus Christi--Cognitive (BASIC-Cognitive)

Completed

Drug Details

Intervention Type
OTHER
Total Trials
176